Fasting-Mimicking Diet May Benefit Crohn’s Disease | Study Results

For individuals living with Crohn’s disease, finding effective management strategies can be a long and often frustrating journey. While medications play a crucial role for many, a growing body of research suggests that dietary interventions may also offer significant benefits, particularly for those with mild to moderate symptoms. A recent study, led by researchers at Stanford Medicine, indicates that a five-day-a-month fasting-mimicking diet (FMD) could reduce inflammation and alleviate symptoms associated with the condition.

The trial, published in January 13, 2026, in Nature Medicine, involved 97 participants with mild to moderate Crohn’s disease. Participants followed the FMD for five consecutive days each month, restricting their caloric intake to between 700 and 1100 calories. This wasn’t a typical fast, however. The diet was specifically designed to mimic the effects of fasting while still allowing for some food consumption. The meal plan emphasized plant-based foods, excluding animal products, sugar, rice, and grains. Allowed foods included vegetable soups and stews, olives, kale crackers, and nut bars, supplemented with vitamins, minerals, and omega-3 fatty acids.

“We have been very limited in what kind of dietary information we can provide patients,” said Sidhartha R. Sinha, MD, an assistant professor of gastroenterology and hepatology at Stanford Medicine and the senior author of the study. “This study will give physicians evidence to support recommendations in an area that patients are very curious about.”

Understanding Crohn’s Disease and the Need for Dietary Approaches

Crohn’s disease is a chronic inflammatory condition affecting the digestive tract. The immune system mistakenly attacks parts of the gut, leading to symptoms like abdominal pain, diarrhea, fatigue, and unintended weight loss. The disease typically follows a cyclical pattern of flares and periods of remission. While medications are often effective, treatment options are limited for individuals with milder forms of the disease, and there are currently no FDA-approved therapies specifically for long-term maintenance in these cases beyond steroids, which can have significant side effects with prolonged use.

This gap in treatment options has fueled patient interest in exploring dietary modifications as a potential means of managing their condition. However, robust scientific evidence supporting specific dietary interventions has been scarce – until now. The Stanford-led trial represents the largest randomized controlled trial of an oral diet intervention in adults with Crohn’s disease to date, providing a higher level of evidence than previously available.

How Does a Fasting-Mimicking Diet Work?

The fasting-mimicking diet is designed to temporarily shift the body into a metabolic state similar to that of a fast, without requiring complete food deprivation. By restricting calorie intake and macronutrient composition, the FMD aims to reduce inflammation, promote cellular repair, and potentially alter the gut microbiome. The specific composition of the diet is crucial, as it provides enough nutrients to prevent significant muscle loss while still triggering the desired metabolic effects.

Research suggests that intermittent fasting, and specifically time-restricted eating, can be effective for people with Crohn’s disease who want to lose weight. A study conducted by researchers at the University of Calgary and the University of British Columbia, Okanagan Campus (UBCO) found that participants who fasted for 16 consecutive hours per day, six days per week, for 12 weeks experienced weight loss, reduced visceral fat, decreased inflammation, and fewer symptoms. “Maintaining a healthy body weight for people with Crohn’s disease is very important,” explained Dr. Maitreyi Raman, MD, a gastroenterologist and associate professor at UCalgary’s Cumming School of Medicine, and principal investigator of the study.

Implications and Future Research

The findings from the Stanford study and the University of Calgary/UBCO research offer a promising new avenue for managing Crohn’s disease, particularly for individuals with mild to moderate symptoms. While the exact mechanisms by which the FMD exerts its effects are still being investigated, the observed reductions in inflammation and symptom improvement suggest a potential role for dietary interventions in the overall management of the condition.

It’s important to note that these dietary approaches are not a one-size-fits-all solution. Individuals with Crohn’s disease should always consult with their healthcare provider before making any significant changes to their diet. The FMD, in particular, requires careful planning and monitoring to ensure it is safe and appropriate for each individual. Further research is needed to determine the optimal duration and frequency of the FMD, as well as its long-term effects on disease progression.

The increasing evidence supporting dietary interventions for Crohn’s disease represents a significant shift in the field. As Dr. Sinha noted, this research provides physicians with evidence-based recommendations to address a question patients frequently ask: “What should I eat?” This represents a welcome development for both patients and healthcare providers seeking effective and personalized strategies for managing this chronic inflammatory condition.